In Italy's biotechnology sector, the R&D intensity measured as a share of value added in industry remains stable at 1.5% for 2024 and 2025, decreasing slightly to 1.4% from 2026 to 2028. Compared to 2023, when the intensity was around 1.5%, the sector is experiencing a small decline over the forecast period. The year-on-year variations show stability until 2026, followed by a minor downward trend. The compound annual growth rate reflects a flat to slightly declining R&D intensity, hindering potential competitive edges.
Future trends to watch include investments in biotechnological innovation to enhance the sector's competitiveness and potential shifts in government policies favoring increased R&D expenditures. Monitoring global biotechnology trends and Italy's policy environment may highlight opportunities to reverse the declining intensity and bolster industry capabilities.
